Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP)

Medicine and Dentistry

• Nephropathy 100%
• Placebo 25%
• Proteinuria 15%
• Cyclophosphamide 15%
• Randomized Controlled Trial 10%
• Heparin 10%
• Cyclosporine 10%
• Selection Bias 10%
• Mycophenolate Mofetil 10%
• Microhematuria 10%
• Abdominal Pain 5%
• Arthritis 5%
• Outcome Assessment 5%
• Transplantation 5%
• Antiplatelet 5%
• Bleeding 5%
• Antiplatelet Drug 5%
• Attributable Risk 5%
• Acute Kidney Injury 5%
• Vasculitis 5%
• Random Effects Model 5%
• Nephrotic Syndrome 5%
• Arthralgia 5%
• Azathioprine 5%
• Small Vessel Vasculitis 5%
• Adverse Effect 5%
• Nephritic Syndrome 5%
• Methylprednisolone 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Purpura 100%
• Nephritis 5%
• Small Vessel Vasculitis 5%